Quantcast

Latest Caris Life Sciences Stories

2014-06-24 08:30:59

IRVING, Texas, June 24, 2014 /PRNewswire/ -- Valley Medical Oncology Consultants (VMOC) and Caris Life Sciences announced today a collaboration to establish a clinical molecular profiling program that enables more personalized treatment for cancer patients in the San Francisco Bay Area. This program will leverage the power of Caris Molecular Intelligence(TM), the industry's leading comprehensive tumor profiling service, to better target therapy options based on a patient's unique...

2014-06-05 08:28:09

Median Overall Survival was 8 Years Longer for Women who were Treated with Therapies Consistent with Caris Molecular Intelligence(TM) Tumor Profiling Prediction and was 2 ½ years Longer after Recurrence IRVING, Texas, June 5, 2014 /PRNewswire/ -- Caris Life Sciences® and investigators from Inova Fairfax Hospital presented the first clinical outcomes data presentation from the Caris Registry(TM) at the 50(th) annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago,...

2014-06-03 08:31:30

Pathway Analysis Confirms the Unique Clinical Utility of Caris Molecular Intelligence(TM) CHICAGO, June 3, 2014 /PRNewswire/ -- Caris Life Sciences®, a leading biosciences company focused on fulfilling the promise of precision medicine, announced today the presentation of data identifying multiple novel biomarkers as potential targets for immunotherapeutic agents in triple negative breast cancer (TNBC), an aggressive form of breast cancer in which the cancer cells lack estrogen receptors...

2014-06-02 08:29:15

Combined Gene and Protein Analysis of Sarcoma Confirms the Unique Clinical Utility of Caris Molecular Intelligence(TM) CHICAGO, June 2, 2014 /PRNewswire/ -- Caris Life Sciences®, a leading biosciences company focused on fulfilling the promise of precision medicine, today announced the presentation of data from a study in which multiplatform biomarker assessment was used to identify multiple potential novel targets for the treatment of sarcoma, a type of cancer that begins in bone or in the...

2014-06-01 08:20:22

Large International Cohort of 17 GI Cancer Types Confirms the Unique Clinical Utility of Caris Molecular Intelligence(TM) CHICAGO, June 1, 2014 /PRNewswire/ -- Caris Life Sciences, a leading biosciences company focused on fulfilling the promise of precision medicine, announced today the presentation of clinical data at the 50th Annual Meeting of ASCO in which molecular profiling identified numerous potential drug options in patients with various types of gastrointestinal (GI) cancer. Among...

2014-05-31 08:20:38

Clinical Studies in Gynecologic Cancers Confirm the Unique Clinical Utility of Caris Molecular Intelligence(TM) CHICAGO, May 31, 2014 /PRNewswire/ -- Caris Life Sciences®, a leading biosciences company focused on fulfilling the promise of precision medicine, announced today the presentation of clinical data from studies demonstrating the potential utility of comprehensive molecular profiling in guiding treatment of patients with gynecologic malignancies, including breast cancers and ovarian...

2014-05-30 08:24:40

Role Further Enhances Company's Medical Leadership Capabilities IRVING, Texas, May 30, 2014 /PRNewswire/ -- Caris Life Sciences®, a leading biosciences company focused on fulfilling the promise of precision medicine, announced today that it has named Sandeep K. Reddy, M.D., as its Chief Medical Officer. Dr. Reddy most recently served as Senior Medical Director for Caris before assuming the Chief Medical Officer role. In his new capacity, Dr. Reddy will lead the company's research...

2014-05-29 08:28:58

Appointees join Caris' distinguished clinical and scientific team to accelerate the development and commercialization of innovative precision medicine technologies IRVING, Texas, May 29, 2014 /PRNewswire/ -- Caris Life Sciences®, a leading biosciences company focused on fulfilling the promise of precision medicine, announced today that it has assembled leading scientists and clinical experts to join its newly created Scientific Advisory Board (SAB). This team will assist the...

2014-05-15 08:31:40

Comprehensive Molecular Profiling Provides Oncologists Treating Patients with Rare, Aggressive or Refractory Cancers with Better Understanding of How to Treat Cancer IRVING, Texas, May 15, 2014 /PRNewswire/ -- Caris Life Sciences, a leading biosciences company focused on fulfilling the promise of precision medicine, today announced the acceptance of 34 key clinical studies by the American Society of Clinical Oncology (ASCO) for their 50(th) annual meeting to be held May 30 through June 3 in...

2014-05-12 08:31:04

IRVING, Texas, May 12, 2014 /PRNewswire/ -- North Shore Hematology Oncology Associates (NSHOA) and Caris Life Sciences today announced a collaboration to establish a personalized cancer care program for patients in the greater Long Island area. This program will leverage the power of Caris Molecular Intelligence(TM), the industry's leading comprehensive tumor profiling service, to better target therapy options based on each patient's unique cancer biology. With the addition of this...


Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related